Cardica Inc. received the European CE Mark (Conformite Europeenne) for the C-Port Flex A Anastomosis System, a device that facilitates the automated anastomosis during less invasive coronary artery bypass graft (CABG) procedures.


When it comes to diagnosing disease, image is everything. It is difficult to treat what you can’t see. That’s especially true in the cardiac cath lab where cardiologists performing procedures ranging from simple diagnostic tests to more complex interventional maneuvers rely on imaging technology to guide their course.

New York’s Mount Sinai Heart has it all: a star-studded line-up of internationally renowned physicians, scientists and educators, cutting-edge research and unparalleled clinical services. Their secret to success — an integrated approach to cardiovascular healthcare that makes it all possible.


Since the introduction of the 64 multi-slice CT scanner, studies have examined the utility of this technology for diagnosing coronary artery disease (CAD), and cardiologists are rapidly adopting this technology to perform CT Angiography (CTA) for detecting CAD.

CT scanners have evolved over the years and are showing to have applications in the emergent and non-emergent evaluation of underlying cardiovascular issues. The general acceptance for cardiovascular evaluation by CT is limited due to ongoing studies.

More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.

Of the 1. 57 million annual hospital admissions in the U.S. for acute coronary syndromes, 1.24 million are due to unstable angina and non-ST-segment elevation myocardial infarction (UA/NSTEMI).

September 11, 2007 - Terumo Interventional Systems announces the launch of its breakthrough Runthrough NS Coronary Guidewire in the U.S. market for use in percutaneous transluminal coronary angioplasties (PTCA), as the company expands its position in the coronary market.

Runthrough NS is designed to provide tip durability, complete torque transfer and enhanced steerability. This coronary guidewire boasts efficiency and reliability.

September 11, 2007 – Improving how healthcare providers follow proven protocols could reduce the risks of subsequent heart problems for heart disease patients, according to a study reported in a cardiovascular surgery supplement of Circulation: Journal of the American Heart Association.

A study of the American Heart Association's Get With The GuidelinesSM (GWTG) database found significant differences in how hospitals carry out many of the association's secondary prevention recommendations.

September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now